Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

prnewswire
02/02

The new technology is the world's smallest, catheter-delivered defibrillation lead

AUSTIN, Texas, Feb. 2, 2026 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an FDA-approved novel defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered defibrillation lead, which allows for precise delivery and placement in the right ventricle.

The first procedure was performed by Robert Canby, M.D., and Amin Al-Ahmad, M.D., clinical cardiac electrophysiologists at TCAI, on Jan. 7. Dr. Canby also participated in the trial that led to FDA approval.

"When treating patients, safety and efficacy are paramount, and this novel technology allows us to achieve both with greater precision," said Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI. "This milestone is a testament to the Texas Cardiac Arrhythmia Institute's continued pursuit of innovation that will improve outcomes and access to life-saving care."

A lead senses the heartbeat and transmits signals to the implanted device, which then delivers therapy to correct or interrupt abnormally fast rhythms—called arrhythmias—that can result in sudden cardiac arrest. Existing defibrillation leads are larger in diameter, increasing the potential for future complications.

According to the Journal of the American Heart Association, an estimated 12.1 million people in the U.S. are expected to have atrial fibrillation—the most common arrhythmia—by 2030.

TCAI is a state-of-the-art Electrophysiology Center that includes six labs equipped with advanced technology where a group of esteemed cardiac electrophysiologists—led by Dr. Natale, a world-renowned expert in the field—perform a high volume of the most complex electrophysiology procedures.

SOURCE Texas Cardiac Arrhythmia Institute at St. David’s Medical Center

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10